Stem cell treatment due for a checkup

    Updated: 2012-01-11 09:09

    By Shan Juan (

    China Daily

    )

      Comments() Print Mail Large Medium  Small 分享按鈕 0

    BEIJING - China's top health authority will strictly regulate the cutting-edge stem cell treatment, which attracts thousands of patients from abroad each year, to ensure patient safety and the orderly development of the technology.

    A one-year overhaul highlighting self-examination among practitioners will be launched to detect and eliminate irregularities surrounding the issue, said Deng Haihua, spokesman of the Ministry of Health at a news conference on Tuesday.

    Stem cell treatment due for a checkup

    "All medical research and clinical practices of stem cell therapy without approval from the ministry and the State Food and Drug Administration will be put to an end after the overhaul," he told China Daily.

    Largely due to concerns over ethics, treatment efficacy, and a lack of relative laws and regulations, the health authority has never approved clinical use of the therapy on the mainland, Deng stressed.

    However, the demand and practice of the treatment have existed for a long time and are rapidly increasing, said Yang Jian, CEO of the Shanghai Medical Tourism Products and Promotion Platform.

    Industry analysis shows that at least 10,000 patients from other countries come to the mainland for the costly procedure each year and roughly 100 facilities are offering the service.

    Yang said some hospitals exploit regulatory loopholes to carry out the controversial therapy, which experts warn has no guarantee for safety and efficacy, he added.

    In China, stem cell therapy is mainly used to treat diabetes, spinal cord injury, cerebral palsy, brain injury and stroke.

    A nurse surnamed Qiao with the stem cell transplantation department of the General Hospital of Chinese People's Armed Police Forces told China Daily on Tuesday that they now have 80 patients, including 10 expats, undergoing stem cell treatment.

    Since 2003, Qiao's department has treated more than 4,000 patients from 15 countries.

    Asked how the overhaul would affect their business, she said because of the hospital's affiliation with the Armed Police, it would not be subject to management by the Ministry of Health.

    Many hospitals with a military background are carrying out the therapy, said Qiu Renzong, a leading bioethicist with the Chinese Academy of Social Sciences.

    To date, only adult stem cells sourced from bone marrow and umbilical cords for treating blood cancer have been proven safe and effective, he said.

    More scientific data in terms of safety and efficacy is needed before stem cell treatment can be applied to humans, according to the World Health Organization.

    Wang Qingyun contributed to this story.

    国模GOGO无码人体啪啪| 青青草无码免费一二三区| 精品日韩亚洲AV无码| 最近中文字幕视频在线资源| 久久亚洲精品无码AV红樱桃| 中文字幕亚洲综合久久菠萝蜜 | 久久精品中文闷骚内射| 粉嫩高中生无码视频在线观看| 中文字幕无码成人免费视频| 中文字幕无码无码专区| 高清无码视频直接看| 成人无码WWW免费视频| 天堂а√中文在线| 国产 欧美 亚洲 中文字幕| 办公室丝袜激情无码播放| 一本无码中文字幕在线观| 天堂在线观看中文字幕| 中文字幕精品一区二区日本| 制服丝袜中文字幕在线| 亚洲一本大道无码av天堂| AV无码精品一区二区三区| 乱色精品无码一区二区国产盗| 国产成人无码一区二区三区在线| 亚洲AV中文无码乱人伦| 日韩久久久久久中文人妻 | 亚洲自偷自偷偷色无码中文| 亚洲国产成人精品无码久久久久久综合| 日韩AV片无码一区二区不卡电影| 亚洲中文字幕无码久久2020| 久久久久久国产精品无码下载| 人妻无码人妻有码中文字幕| 中文精品久久久久人妻不卡 | 最近更新中文字幕第一页| 久久激情亚洲精品无码?V| 88国产精品无码一区二区三区 | 亚洲国产av无码精品| 亚洲精品无码久久不卡| 中文字幕精品无码一区二区三区| 亚洲中文字幕无码日韩| 国产高清中文手机在线观看| 日韩欧美成人免费中文字幕|